Clinical Application of Next-Generation Sequencing in Recurrent Glioblastoma
Onco · 2021
DOI: 10.3390/onco1010005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Onco, 2021. Verfasst von Daniel Zeitouni und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Glioblastoma (GBM) is driven by various genomic alterations. Next-generation sequencing (NGS) could yield targetable alterations that might impact outcomes. The goal of this study was to describe how NGS can inform targeted therapy (TT) in this patient population. METHODS: The medical records of patients with a diagnosis of GBM from 2017 to 2019 were reviewed. Records of patients with recurrent GBM and genomic alterations were evaluated. Objective response rates and disease control rates were determined. RESULTS: A total of 87 patients with GBM underwent NGS. Forty percent (n = 35) were considered to have actionable alterations. Of these 35, 40% (n = 14) had their treatment changed due to the alteration. The objective response rate (ORR) of this population was 43%. The disease control rate (DCR) was 100%. The absolute mean decrease in contrast-enhancing disease was 50.7% (95% CI 34.8–66.6). CONCLUSION: NGS for GBM, particularly in the recurrent setting, yields a high rate of actionable alterations. We observed a high ORR and DCR, reflecting the value of NGS when deciding on therapies to match genomic alterations. In conclusion, patient selection and the availability of NGS might impact outcomes in select patients with recurrent GBM.
Zitieren
APA
Zeitouni, D., Catalino, M. P., Wise, J., McCabe, S., Pietrosimone, K., Rashid, N., & Khagi, S. (2021). Clinical Application of Next-Generation Sequencing in Recurrent Glioblastoma. Onco. https://doi.org/10.3390/onco1010005
Vancouver
Zeitouni D, Catalino MP, Wise J, McCabe S, Pietrosimone K, Rashid N, et al. Clinical Application of Next-Generation Sequencing in Recurrent Glioblastoma. Onco. 2021. doi:10.3390/onco1010005
BibTeX
@article{Zeitouni2021,
author = {Zeitouni, Daniel and Catalino, Michael P. and Wise, Jordan and McCabe, Sean and Pietrosimone, Kathryn and Rashid, Naim and Khagi, Simon},
title = {Clinical Application of Next-Generation Sequencing in Recurrent Glioblastoma},
journal = {Onco},
year = {2021},
doi = {10.3390/onco1010005}
}
EUVIMED